Sun, Y., Cheng, Y., Hao, X., Wang, J., Hu, C., Han, B., . . . Luo, X. (2016). Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer. BMC Cancer.
Citação norma ChicagoSun, Yan, et al. "Randomized Phase III Trial of Amrubicin/cisplatin Versus Etoposide/cisplatin As First-line Treatment for Extensive Small-cell Lung Cancer." BMC Cancer 2016.
Citação norma MLASun, Yan, et al. "Randomized Phase III Trial of Amrubicin/cisplatin Versus Etoposide/cisplatin As First-line Treatment for Extensive Small-cell Lung Cancer." BMC Cancer 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.